On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
On Jun. 13, 2024, the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic…
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
On Jun. 10, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) had granted Emergency Use…
On Jun. 5, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
On June 5, 2024, the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee announced that it had…
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
On May 24, 2024, the World Health Organization (WHO) revealed that the COVID-19 pandemic reversed the trend of…
On May 17, 2024, researchers at Washington University School of Medicine in St. Louis announced a study had…
On May 10, 2024, Novavax announced that it had entered into a co-exclusive licensing agreement with Sanofi. The…
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
On Mar. 27, 2024, the World Health Organization announced it had launched a network for coronaviruses, CoViNet, to…
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued the an emergency use authorization for…
On Mar. 20, 2024, a National Institutes of Health-supported study reported that SARS-CoV-2, the virus that causes COVID-19,…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced study results that showed…
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
On Nov. 23, 2023, the World Health Organization (WHO) announced that it was monitoring data from Chinese surveillance…
On Nov. 6, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that it was conducting…
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
On Sept. 28, 2023, the National Institute of health announced SARS-CoV-2, the virus that causes COVID-19, can directly…
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…